Literature DB >> 19628645

Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients.

Hiroki Ueno1, Hidenori Koyama, Shinya Fukumoto, Shinji Tanaka, Takuhito Shoji, Tetsuo Shoji, Masanori Emoto, Hideki Tahara, Yoshihiro Tsujimoto, Tsutomu Tabata, Yoshiki Nishizawa.   

Abstract

BACKGROUND: Numbers of endothelial progenitor cells (EPC) have been shown to be decreased in subjects with end-stage renal disease (ESRD). It is not clear, however, whether dialysis modality affects circulating EPCs in ESRD subjects.
METHODS: We examined the number of circulating EPCs in 67 continuous ambulatory peritoneal dialysis (CAPD) patients and age- and gender-matched 142 haemodialysis (HD) patients, and 78 subjects without chronic kidney disease. Arterial stiffness was analysed as pulse-wave velocity (PWV) for these patients, and their mutual relationship with circulating EPCs was examined. EPCs were measured as CD34(+) CD133(+) CD45(low) VEGFR2(+) cells determined by flow cytometry.
RESULTS: The EPC numbers exhibited a strong correlation (R(2) = 0.866) with endothelial-colony forming units on culture assay. The levels of EPCs in HD or CAPD subjects were significantly lower than those in control subjects. Among ESRD subjects, the levels of EPC were significantly higher in CAPD subjects than those in HD subjects. In ESRD subjects, PWV levels tended to be associated with EPCs (Rs = -0.131, P = 0.058). However, the significant relationship between dialysis modality and circulating EPCs was independent of the levels of PWV. The association of circulating EPCs with dialysis modality was significant even after adjusting for other potential confounders, including age, gender, blood pressure, history of cardiovascular diseases, presence of diabetes, blood haemoglobin level and treatments with angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker or statin.
CONCLUSIONS: CAPD treatment could be a positive regulator of number of circulating EPCs in subjects with ESRD, with the relationship independent of the status of arteriosclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 19628645     DOI: 10.1093/ndt/gfp358

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

Review 1.  Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease?

Authors:  Rajesh Mohandas; Mark S Segal
Journal:  Blood Purif       Date:  2010-01-08       Impact factor: 2.614

Review 2.  Challenges and opportunities for stem cell therapy in patients with chronic kidney disease.

Authors:  LaTonya J Hickson; Alfonso Eirin; Lilach O Lerman
Journal:  Kidney Int       Date:  2016-01-26       Impact factor: 10.612

3.  Circulating angiogenic stem cells in type 2 diabetes are associated with glycemic control and endothelial dysfunction.

Authors:  Nagma Zafar; Sathya S Krishnasamy; Jasmit Shah; Shesh N Rai; Daniel W Riggs; Aruni Bhatnagar; Timothy E O'Toole
Journal:  PLoS One       Date:  2018-10-15       Impact factor: 3.240

4.  Endothelial Progenitor Cells and Vascular Health in Dialysis Patients.

Authors:  Brooke M Huuskes; Ryan J DeBuque; Kevan R Polkinghorne; Chrishan S Samuel; Peter G Kerr; Sharon D Ricardo
Journal:  Kidney Int Rep       Date:  2017-09-18

5.  Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency.

Authors:  Anurag Mehta; Ayman S Tahhan; Chang Liu; Devinder S Dhindsa; Aditi Nayak; Ananya Hooda; Kasra Moazzami; Shabatun J Islam; Steven C Rogers; Zakaria Almuwaqqat; Ali Mokhtari; Iraj Hesaroieh; Yi-An Ko; Edmund K Waller; Arshed A Quyyumi
Journal:  JACC Basic Transl Sci       Date:  2020-08-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.